Literature DB >> 10377084

Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice.

T Couffinhal1, M Silver, M Kearney, A Sullivan, B Witzenbichler, M Magner, B Annex, K Peters, J M Isner.   

Abstract

BACKGROUND: The impact of disordered lipid metabolism on collateral vessel development was studied in apolipoprotein (apo)E-/- mice with unilateral hindlimb ischemia. METHODS AND
RESULTS: Hindlimb blood flow and capillary density were markedly reduced in apoE-/- mice versus C57 controls. This was associated with reduced expression of vascular endothelial growth factor (VEGF) in the ischemic limbs of apoE-/- mice. Cell-specific immunostaining localized VEGF protein expression to skeletal myocytes and infiltrating T cells in the ischemic limbs of C57 mice; in contrast, T-cell infiltrates in ischemic limbs of apoE-/- mice were severely reduced. The critical contribution of T cells to VEGF expression and collateral vessel growth was reinforced by the finding of accelerated limb necrosis in athymic nude mice with operatively induced hindlimb ischemia. Adenoviral VEGF gene transfer to apoE-/- mice resulted in marked augmentation of hindlimb blood flow and capillary density.
CONCLUSIONS: These findings thus underscore the extent to which hyperlipidemia adversely affects native collateral development but does not preclude augmented collateral vessel growth in response to exogenous cytokines. Moreover, results obtained in the apoE-/- and athymic nude mice imply a critical role for infiltrating T cells as a source of VEGF in neovascularization of ischemic tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377084     DOI: 10.1161/01.cir.99.24.3188

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  58 in total

Review 1.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Authors:  J M Isner; T Asahara
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.

Authors:  Jaeyun Kim; Lan Cao; Dmitry Shvartsman; Eduardo A Silva; David J Mooney
Journal:  Nano Lett       Date:  2010-12-30       Impact factor: 11.189

3.  A systematic approach to assess locoregional differences in angiogenesis.

Authors:  T Driesen; D Schuler; R Schmetter; C Heiss; M Kelm; J W Fischer; T Freudenberger
Journal:  Histochem Cell Biol       Date:  2015-11-02       Impact factor: 4.304

4.  Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

Authors:  Vivek Mahajan; Zagit Gaymalov; Daria Alakhova; Richa Gupta; Irving H Zucker; Alexander V Kabanov
Journal:  Biomaterials       Date:  2015-10-09       Impact factor: 12.479

Review 5.  Coronary vessel development and insight towards neovascular therapy.

Authors:  Nicola Smart; Karina N Dubé; Paul R Riley
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

6.  Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.

Authors:  Nicholas A Dewyer; Vikram Sood; Erin M Lynch; Catherine E Luke; Gilbert R Upchurch; Thomas W Wakefield; Steven Kunkel; Peter K Henke
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

7.  Effects of VEGF temporal and spatial presentation on angiogenesis.

Authors:  Eduardo A Silva; David J Mooney
Journal:  Biomaterials       Date:  2009-11-10       Impact factor: 12.479

8.  Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors.

Authors:  Cristina Borselli; Hannah Storrie; Frank Benesch-Lee; Dmitry Shvartsman; Christine Cezar; Jeff W Lichtman; Herman H Vandenburgh; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

9.  Divergent systemic and local inflammatory response to hind limb demand ischemia in wild-type and ApoE-/- mice.

Authors:  Robert S Crawford; Hassan Albadawi; Alessandro Robaldo; Michael A Peck; Christopher J Abularrage; Hyung-Jin Yoo; Glenn M Lamuraglia; Michael T Watkins
Journal:  J Surg Res       Date:  2013-03-15       Impact factor: 2.192

10.  Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis.

Authors:  Qinghua Sun; Eduardo A Silva; Aixia Wang; James C Fritton; David J Mooney; Mitchell B Schaffler; Paul M Grossman; Sanjay Rajagopalan
Journal:  Pharm Res       Date:  2009-12-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.